Zentek Ltd. Regains Nasdaq Compliance re Minimum Bid Price
Zentek has successfully regained compliance with Nasdaq's minimum bid price requirement. The company received notification from Nasdaq on December 3, 2024, confirming that it has met the listing rule 5550(a)(2), which requires securities to maintain a minimum bid price of US$1.00 per share. Zentek's common stock has traded above the US$1.00 threshold for 11 consecutive business days, satisfying the requirement.
Zentek ha ripristinato con successo il rispetto del requisito di prezzo minimo di offerta di Nasdaq. L'azienda ha ricevuto notifica da Nasdaq il 3 dicembre 2024, confermando di aver soddisfatto la regola di quotazione 5550(a)(2), che richiede ai titoli di mantenere un prezzo minimo di offerta di 1,00 USD per azione. Le azioni comuni di Zentek sono state scambiate a un prezzo superiore alla soglia di 1,00 USD per 11 giorni lavorativi consecutivi, soddisfacendo così il requisito.
Zentek ha recuperado con éxito el cumplimiento del requisito del precio mínimo de oferta de Nasdaq. La empresa recibió una notificación de Nasdaq el 3 de diciembre de 2024, confirmando que ha cumplido con la regla de listado 5550(a)(2), que exige que los valores mantengan un precio mínimo de oferta de 1.00 USD por acción. Las acciones comunes de Zentek se han negociado por encima del umbral de 1.00 USD durante 11 días hábiles consecutivos, cumpliendo así con el requisito.
젠텍은 나스닥의 최소 입찰가 요구 사항을 성공적으로 회복했습니다. 이 회사는 2024년 12월 3일 나스닥으로부터 5550(a)(2) 상장 규정을 충족했다는 통지를 받았으며, 이 규정은 증권이 주당 최소 입찰가 1.00 USD를 유지해야 한다고 요구합니다. 젠텍의 보통주 주가는 연속 11 거래일 이상 1.00 USD 이상으로 거래되어 요구 사항을 충족했습니다.
Zentek a réussi à restaurer sa conformité avec l'exigence de prix d'offre minimum de Nasdaq. L'entreprise a reçu une notification de Nasdaq le 3 décembre 2024, confirmant qu'elle a respecté la règle de cotation 5550(a)(2), qui exige que les valeurs mobilières maintiennent un prix d'offre minimum de 1,00 USD par action. L'action ordinaire de Zentek a été échangée au-dessus du seuil de 1,00 USD pendant 11 jours ouvrables consécutifs, satisfaisant ainsi à l'exigence.
Zentek hat erfolgreich die Einhaltung der Mindestgebotsanforderungen von Nasdaq wiederhergestellt. Das Unternehmen erhielt am 3. Dezember 2024 eine Mitteilung von Nasdaq, dass es die Listing-Regel 5550(a)(2) erfüllt hat, die von den Wertpapieren verlangt, mindestens einen Gebotskurs von 1,00 USD pro Aktie zu halten. Die Stammaktien von Zentek wurden während 11 aufeinanderfolgender Handelstage über der 1,00 USD-Grenze gehandelt und haben damit die Anforderungen erfüllt.
- Regained Nasdaq listing compliance, eliminating risk of delisting
- Stock price maintained above US$1.00 for 11 consecutive business days
- Previous trading below US$1.00 indicates recent stock price weakness
Insights
The regaining of Nasdaq compliance is a positive development for Zentek, removing a significant regulatory overhang and potential delisting risk. This milestone demonstrates improved market confidence and stability in the stock's trading price. However, maintaining compliance will require sustained trading above
For a small-cap company with a market cap of
GUELPH, ON / ACCESSWIRE / December 9, 2024 / Zentek Ltd. ("Zentek"or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that on December 3, 2024, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common stock ("Common Stock") has been above US
Nasdaq Listing Rules
Nasdaq Listing Rule 5550(a)(2) requires securities listed on the Nasdaq Capital Market to maintain a minimum bid price of US
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™ is shown to have enhanced viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is located in Guelph, Ontario.
For further information on Zentek:
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek
View the original press release on accesswire.com
FAQ
When did Zentek (ZTEK) regain Nasdaq compliance?
What was the minimum bid price requirement for Zentek (ZTEK) to maintain Nasdaq listing?